tykhr
sign in
free sign up
Intercept Pharmaceuticals Inc
Biotechnology
Healthcare
ICPT
41.73 M shares
NASDAQ US
traded
07 Nov 2023
listed
yes
open
19.00
52 week high
21.71
high
19.01
52 week low
9.17
low
18.98
growth
25.83 %
previous Close
18.96
P/E ratio
market cap
437 M
div yield
0
usd
Jun 2023
qoq
revenue
83.72 M
23.19 %
net incoming
-5.86 M
80.18 %
eps
0.00 %
81.82 %
eps surprise
72.55 %
net profit margin
-7.00 %
36.00 %
operating incoming
-7.12 M
77.49 %
net change in cash
400 K
-94.42 %
cash on hand
136 M
121.86 %
cost of revenue
185 K
-16.67 %
top